These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21506982)

  • 1. A case report of Gianotti-Crosti post vaccination with MMR and dTaP.
    Atanasovski M; Dele-Michael A; Dasgeb B; Ganger L; Mehregan D
    Int J Dermatol; 2011 May; 50(5):609-10. PubMed ID: 21506982
    [No Abstract]   [Full Text] [Related]  

  • 2. Gianotti-Crosti syndrome after childhood vaccination.
    Retrouvey M; Koch LH; Williams JV
    Pediatr Dermatol; 2012; 29(5):666-8. PubMed ID: 22352961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.
    Shinefield H; Black S; Thear M; Coury D; Reisinger K; Rothstein E; Xu J; Hartzel J; Evans B; Digilio L; Schödel F; Brown ML; Kuter B;
    Pediatr Infect Dis J; 2006 Apr; 25(4):287-92. PubMed ID: 16567978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gianotti-Crosti syndrome following childhood vaccinations.
    Retrouvey M; Koch LH; Williams JV
    Pediatr Dermatol; 2013; 30(1):137-8. PubMed ID: 22141410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and safety of a combined DTaP-IPV vaccine compared with separate DTaP and IPV vaccines when administered as pre-school booster doses with a second dose of MMR vaccine to healthy children aged 4-6 years.
    Black S; Friedland LR; Schuind A; Howe B;
    Vaccine; 2006 Aug; 24(35-36):6163-71. PubMed ID: 16759769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gianotti-Crosti syndrome following immunization].
    Haug S; Schnopp C; Ring J; Fölster-Holst R; Abeck D
    Hautarzt; 2002 Oct; 53(10):683-5. PubMed ID: 12297951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and safety of a combined hepatitis A and B vaccine administered concomitantly with either a measles-mumps-rubella or a diphtheria-tetanus-acellular pertussis-inactivated poliomyelitis vaccine mixed with a Haemophilus influenzae type b conjugate vaccine in infants aged 12-18 months.
    Usonis V; Meriste S; Bakasenas V; Lutsar I; Collard F; Stoffel M; Tornieporth N
    Vaccine; 2005 Apr; 23(20):2602-6. PubMed ID: 15780442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.
    Black S; Friedland LR; Ensor K; Weston WM; Howe B; Klein NP
    Pediatr Infect Dis J; 2008 Apr; 27(4):341-6. PubMed ID: 18316985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
    Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
    Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic allergic reactions to gelatin included in vaccines as a stabilizer.
    Sakaguchi M; Inouye S
    Jpn J Infect Dis; 2000 Oct; 53(5):189-95. PubMed ID: 11135703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New combination vaccines: DTaP-IPV (Kinrix) and DTaP-IPV/Hib (Pentacel).
    Johns TL; Hutter GE
    Ann Pharmacother; 2010 Mar; 44(3):515-23. PubMed ID: 20197476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of vaccinations on seizure risk and disease course in Dravet syndrome.
    Verbeek NE; van der Maas NA; Sonsma AC; Ippel E; Vermeer-de Bondt PE; Hagebeuk E; Jansen FE; Geesink HH; Braun KP; de Louw A; Augustijn PB; Neuteboom RF; Schieving JH; Stroink H; Vermeulen RJ; Nicolai J; Brouwer OF; van Kempen M; de Kovel CG; Kemmeren JM; Koeleman BP; Knoers NV; Lindhout D; Gunning WB; Brilstra EH
    Neurology; 2015 Aug; 85(7):596-603. PubMed ID: 26203087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
    Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine.
    Langley JM; Predy G; Guasparini R; Law B; Diaz-Mitoma F; Whitstitt P; Tapiero B; Dionne M; Tomovici A; Mills E; Halperin SA
    Vaccine; 2007 Jan; 25(6):1121-5. PubMed ID: 17045366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous Development of Gianotti-Crosti Syndrome and Erythema Multiforme Following Second Dose of Measles-rubella Vaccine.
    Oka M
    Acta Derm Venereol; 2021 Apr; 101(4):adv00438. PubMed ID: 33880572
    [No Abstract]   [Full Text] [Related]  

  • 16. [Contradictory whether paracetamol is contraindicated after childhood vaccination].
    Eriksen J; Gustafsson LL
    Lakartidningen; 2013 Jun 18-Jul 2; 110(25-26):1227. PubMed ID: 23865264
    [No Abstract]   [Full Text] [Related]  

  • 17. Resumption of routine schedule for diphtheria and tetanus toxoids and acellular pertussis vaccine and for measles, mumps, and rubella vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Jul; 51(27):598-9. PubMed ID: 12143834
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypotonic and hyporesponsive episodes after diptheria-tetanus-acellular pertussis vaccination.
    Cherry JD; Karam AG
    Pediatr Infect Dis J; 2007 Oct; 26(10):966-7. PubMed ID: 17901810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of booster immunisation with a combination DTPa-IPV vaccine or DTPa plus IPV in separate injections when co-administered with MMR, at age 4-6 years.
    Marshall H; Nolan T; Roberton D; Richmond P; Lambert S; Jacquet JM; Schuerman L
    Vaccine; 2006 Aug; 24(35-36):6120-8. PubMed ID: 16822597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
    Zepp F; Knuf M; Habermehl P; Mannhardt-Laakmann W; Howe B; Friedland LR
    J Pediatr; 2006 Nov; 149(5):603-610. PubMed ID: 17095328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.